Professor Oral summarises her key take home messages from her Aegerion-sponsored satellite symposium.
Speaker's disclosures: Professor Oral is a consultant to Aegerion Pharmaceuticals with approved fee, has carried out research and consulting work for Akcea Therapeutics/Ionis Pharmaceuticals, and grant support from all of the above and Gemphire Therapeutics.
This video is intended for health care professionals.
Information for patients and carers can be found here
Product information on metreleptin is available here
Adverse reactions should be reported to Aegerion by email: Medinfo.email@example.com or by telephoning the free phone number: 00800 234 37466
Filmed at the European Association for the Study of Diabetes (EASD) annual meeting, Berlin, Germany, 2018